Y-mAbs Therapeutics, Inc. YMAB
8.61 0.00 (+0.00%)
At closeSep 16, 2025, 4:00 PM EDT
8.61 Day range 8.61
6.48 52-week range 20.90
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2024 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 87.69M | 84.82M | 65.27M | 34.90M | 20.75M | |
| 87.69M | 84.82M | 65.27M | 34.90M | 20.75M | |
| 15.25M | 11.42M | 7.57M | 2.51M | 2.20M | |
| 72.43M | 73.40M | 57.70M | 32.38M | 18.55M | |
| 103.64M | 99.08M | 152.51M | 147.82M | 138.48M | |
| 48.99M | 54.22M | 91.57M | 93.25M | 93.70M | |
| 54.65M | 44.86M | 60.94M | 54.57M | 44.78M | |
| -31.20M | -25.67M | -94.81M | -115.43M | -119.94M | |
| -1.39M | -4.81M | 757.00K | 1.85M | -598.00K | |
| -146.00K | 561.00K | 0 | 0 | 0 | |
| -29.67M | -21.43M | -95.57M | -55.27M | -119.34M | |
| -29.67M | -21.43M | -95.57M | -55.27M | -119.34M | |
| -29.67M | -21.43M | -95.57M | -55.27M | -119.34M | |
| -29.67M | -21.43M | -95.57M | -55.27M | -119.34M | |
| -0.67 | -0.49 | -2.19 | -1.28 | -2.97 | |
| -0.67 | -0.49 | -2.19 | -1.28 | -2.97 | |
| -0.67 | -0.49 | -2.19 | -1.28 | -2.97 | |
| -31.20M | -25.67M | -94.81M | -53.42M | -119.94M | |
| -31.20M | -25.67M | -94.81M | -53.42M | -119.94M | |
| 44.33M | 43.65M | 43.70M | 43.18M | 40.12M | |
| 44.33M | 43.65M | 43.70M | 43.18M | 40.12M |